| Document Date: 2014-09-12 17:00:42
Open Document File Size: 65,30 KBShare Result on Facebook
City Drive Glendale / / Company Crealta Pharmaceuticals LLC / / IndustryTerm colorless solution / rubber / healthcare / / MedicalCondition arrhythmia / allergic reaction / Congestive Heart Failure / necrosis / zona fasciculata / hypertension / chest pain / flushing / disease / left ventricular dysfunction / nasopharyngitis / dyspnea / cardiac failure / Carcinogenesis / chronic / nausea / dyslipidemia / skin rash / anaphylaxis / diabetes / erythema / gouty arthritis / vomiting / gout / chronic kidney disease / diabetes mellitus / urticaria / coronary artery disease / hypersensitivity / zona reticularis / symptomatic gout / chronic gout refractory / Deficiency / inflammation / constipation / pruritus / rash / methemoglobinemia / wheezing / / MedicalTreatment intravenous infusions / intravenous infusion / / Organization FDA / / / Position Counsel / physician / Major / Fisher / General / / Product acetaminophen / Sodium Chloride / allopurinol / / ProvinceOrState Wisconsin / / Region Mediterranean / / Technology Pharmacokinetics / mPEG / antibodies / microwave / Pharmacodynamics / digital photography / / URL www.fda.gov/medwatch / /
SocialTag |
well-controlled studies in pregnant women. KRYSTEXXA should be used during pregnancy only if clearly needed. Pegloticase was not teratogenic in rats administered 0, 5, 10, or 40 mg/kg twice weekly by the intravenous rout